Associate Director, Regulatory Affairs

Company Description

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on X, Facebook, Instagram, You Tube, Linked In and Tik Tok.

• Define and implement Area & Affiliate regulatory strategies & deliverables for a portfolio of compounds (early development, late development, marketed) for the Europe Region.
• Identify and advocate region’s requirements in the overarching global regulatory strategy; develop risk assessment of the project(s) and make sure it is considered at the GRPT.
• Line management of team of Senior Regulatory / Regulatory Affairs managers
• Primary RA interface with Commercial Area and in collaboration with the RA personnel in the affiliates.
• Primary interface to and from the RA personnel in the affiliates.

• Define and implement regulatory strategies and deliverables for early and late development compounds and marketed products with significant development activity in the assigned Therapeutic Area for the Europe Region.
• Identify and advocate region’s requirements in the overarching global regulatory strategy; develop risk assessment of the project(s) and make sure it is considered at the GRPT, LRST and other appropriate forums. Duly reports on activities in these teams and alerts the TA Head when necessary.
• Effectively lead planning, preparation and delivery of complex submissions / development programmes from regional perspective working in a matrix leadership environment.
• Assess scientific data provided by specialist units for development activities e.g. scientific advice, special designations and registration purposes against Europe regulatory requirements, identifying gaps and developing mitigation strategies. Ensure effective presentation of data, complete and timely responses. Supports clinical trials strategy as required.
• Develop a Local Regulatory Strategic Plan in collaboration with the RA personnel in the affiliates to elaborate the region’s position on specific projects. Act as ARPT lead.
• Primary RA interface with Europe Market Access and Medical Affairs for early touch points and represent RA in Area Brand Team (ABT) as applicable to provide strategic input for regulatory approval, ensure the business needs are met by anticipating and mitigating regulatory risks while ensuring compliance with regulations, assess probability of success for submission, approval and launch by country and product.
• Primary interface to and from the RA personnel in the affiliates.
• Responsible for direct liaison with EMA for products within the Therapeutic area. Manage EMA meetings and other agency key meetings in liaison with affiliate regulatory managers as applicable. Receives delegation to manage EU agency hearings.
• Provide leadership and support to RA personnel in the affiliates (through ongoing communication, assist in the development, training and mentoring of regulatory leaders).
• Maintain an active awareness of EU and non-EU legislation and assess its impact on Abb Vie business and R&D programs jointly with RPI. Develop and execute strategies to respond to those. Propose revisions. Ensure application of policies once established.
• Broadly applies regulatory/technical knowledge of regulations and skills across therapeutic areas and is generally recognized as a resource & subject matter expert (SME) for Regulatory.
• Ensure regulatory compliance within Europe for assigned compounds/products. Implement remediation plan to address identified gaps, if any.
• Line management of a team of Europe Area Regulatory professionals and mentoring and coaching to other members of the team.

• The incumbent’s decisions can affect sales, marketing, supply chain and clinical trials.
• The incumbent’s decision can affect the company’s image and credibility towards…